Iovance Biotherapeutics (IOVA) Preferred Shares (2013 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Preferred Shares of $2000.0 for Q1 2026, little changed year-over-year from $2000.0 in Q1 2025, and little changed quarter-over-quarter from $2000.0 in Q4 2025.
Iovance Biotherapeutics (IOVA) Preferred Shares (2013 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Preferred Shares for 12 consecutive years, with $2000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Preferred Shares changed 0.0% year-over-year to $2000.0; the TTM figure through Mar 2026 stood at $2000.0 (changed 0.0% YoY), while the FY2025 annual figure was $2000.0, down 33.33% from the prior year.
- Preferred Shares was little changed at $2000.0 in Q1 2026 per IOVA's latest filing, from $2000.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $3000.0 in Q3 2022 and bottomed at $2000.0 in Q1 2025.
- Historically, Preferred Shares has averaged $2615.4 across 5 years, with a median of $3000.0 in 2022.
- Annual changes were most pronounced in 2022 — Preferred Shares changed 0.0% — and 2025, when it plunged 33.33%.
- Iovance Biotherapeutics' Preferred Shares stood at $3000.0 in 2022, then changed by 0.0% to $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then plunged by 33.33% to $2000.0 in 2025, then changed by 0.0% to $2000.0 in 2026.
- Business Quant data shows IOVA's Preferred Shares at $2000.0 in Q1 2026, $2000.0 in Q4 2025, and $2000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Dec 31, 2020 | 4,000.00 |
| Sep 30, 2020 | 4,000.00 |